|
WO2013103317A1
|
|
Quinoline compounds which are anti-angiogenic integrin alpha5 betal inhibitors for use in the treatment of fibrosis or fibrosis-related diseases
|
|
SG176167A1
|
|
Substituted quinolines for use as vegf inhibitors
|
|
WO2010133672A1
|
|
Derivatives of quinoline-3-carboxylic acid and their medical use
|
|
ZA201002885B
|
|
Quinoline derivatives and their use as tyrosine kinase inhibitors
|
|
UA102082C2
|
|
Quinoline derivatives and their use as tyrosine kinase inhibitors
|
|
HUE025421T2
|
|
Quinoline derivatives, pharmaceutical compositions comprising them, and use thereof
|
|
WO2008119771A2
|
|
Quinoline-s-carboxylic acid derivatives as tyrosine kinase inhibitors
|
|
WO2007139496A1
|
|
Quinoline derivatives acting as tyrosine kinase inhibitors
|
